A detailed history of Candriam S.C.A. transactions in Viatris Inc stock. As of the latest transaction made, Candriam S.C.A. holds 100,806 shares of VTRS stock, worth $1.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
100,806
Previous 109,295 7.77%
Holding current value
$1.18 Million
Previous $1.16 Million 0.78%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$10.32 - $12.13 $87,606 - $102,971
-8,489 Reduced 7.77%
100,806 $1.17 Million
Q2 2024

Aug 05, 2024

BUY
$10.05 - $12.02 $210,627 - $251,915
20,958 Added 23.73%
109,295 $1.16 Million
Q1 2024

May 03, 2024

BUY
$11.27 - $13.53 $6,130 - $7,360
544 Added 0.62%
88,337 $1.05 Million
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $243,674 - $301,467
27,785 Added 46.3%
87,793 $950,000
Q2 2023

Aug 08, 2023

SELL
$9.02 - $10.29 $38,939 - $44,421
-4,317 Reduced 6.71%
60,008 $598,000
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $32,199 - $42,910
3,500 Added 5.75%
64,325 $618,000
Q4 2022

Feb 13, 2023

SELL
$8.72 - $11.56 $84,366 - $111,843
-9,675 Reduced 13.72%
60,825 $676,000
Q3 2022

Nov 10, 2022

SELL
$8.48 - $11.13 $104,990 - $137,800
-12,381 Reduced 14.94%
70,500 $601,000
Q2 2022

Aug 03, 2022

BUY
$9.95 - $12.27 $37,193 - $45,865
3,738 Added 4.72%
82,881 $868,000
Q1 2022

May 13, 2022

SELL
$9.81 - $15.4 $1.85 Million - $2.9 Million
-188,409 Reduced 70.42%
79,143 $861,000
Q4 2021

Feb 10, 2022

SELL
$12.09 - $14.68 $56,641 - $68,775
-4,685 Reduced 1.72%
267,552 $3.62 Million
Q3 2021

Nov 09, 2021

SELL
$13.25 - $15.13 $47,739 - $54,513
-3,603 Reduced 1.31%
272,237 $3.69 Million
Q2 2021

Jul 20, 2021

BUY
$12.97 - $16.15 $250,191 - $311,533
19,290 Added 7.52%
275,840 $3.94 Million
Q4 2020

Jan 22, 2021

BUY
$14.3 - $18.74 $3.67 Million - $4.81 Million
256,550 New
256,550 $4.81 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.